Practice

Study Suggests Biosimilar Suffixes Influence Patient Willingness to Switch

September 8, 2020

Deana Ferreri, PhD

Article

The random jumble of letters that the FDA attaches to new biologics and biosimilars plays a big role in patient acceptance of these drugs, investigators report.

Expert Opinion Roundup: Overcoming Barriers to Biosimilar Uptake

September 7, 2020

Skylar Jeremias

Article

This summer, The Center for Biosimilars® interviewed several experts for their opinions on the current need for biosimilars and how companies are working to overcome barriers to uptake. Here are some highlights.

Opinion: Incorporate Nocebo Planning Into IBD Treatment Strategy

September 3, 2020

Tony Hagen

Article

Multiple studies indicate the nocebo effect is particularly influential in the treatment of inflammatory bowel disease (IBD), according to an opinion piece.

Bio-Thera Begins Phase 1 Trial for Ustekinumab Biosimilar

September 3, 2020

Skylar Jeremias

Article

Bio-Thera said it has begun testing the safety its ustekinumab biosimilar in healthy volunteers.

Biosimilar Developers and the Battle Against COVID-19

September 1, 2020

Skylar Jeremias

Article

A look at efforts biosimilar manufacturers are taking to develop treatments for coronavirus disease 2019 (COVID-19).

Investigators Eye Gaps in Biosimilar Assessment Reports

August 31, 2020

Deana Ferreri, PhD

Article

Health technology tssessments play an important role in building confidence for use of biosimilars, yet very few meet criteria for thoroughness.

Biocon, Mylan Launch Semglee and Seek Biosimilar, Interchangeable Status

August 31, 2020

Tony Hagen

Article

For all intents and purposes, Semglee is a biosimilar insulin, but official biosimilar status is needed to clinch the marketing aspect.

Updated "User's Guide" Published for Anti-TNFs in IBD

August 27, 2020

Deana Ferreri, PhD

Article

Two decades of using anti–tumor necrosis factor (TNF) drugs in inflammatory bowel disease (IBD) have answered some questions and left others unanswered.

ACCC's McBride on the Need for Biosimilar Education

August 18, 2020

The Center for Biosimilars

Article

Ali Mcbride, PharmD, MS, BCOP, is taking a lead role in promoting the use and understanding of biosimilars in oncology.

Biosimilars Gain Market Share and Advocates Get Aboard

August 15, 2020

Skylar Jeremias

Article

There has been an outpouring of advocacy tugging biosimilars into the marketplace, and market share of these lower-cost drugs has increased.

x